Strategies at the Interface of Drug Discovery and Development: Early Optimization of the Solid State Phase and Preclinical Toxicology Formulation for Potential Drug Candidates

被引：45
|
作者：
Palucki, Michael [1 ]
Higgins, John D. [1 ]
Kwong, Elizabeth [1 ]
Templeton, Allen C. [1 ]
机构：
[1] Merck & Co Inc, Basic Pharmaceut Sci, Merck Res Labs, West Point, PA 19486 USA
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2010年 / 53卷 / 16期
关键词：
DISSOLUTION; SOLUBILITY; SELECTION; BIOAVAILABILITY; ABSORPTION; DELIVERY;
D O I：
10.1021/jm1002638
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
[No abstract available]
引用
收藏
页码：5897 / 5905
页数：9
相关论文
共 50 条
  • [1] Drug Metabolism in Preclinical Drug Development: A Survey of the Discovery Process, Toxicology, and Computational Tools
    Issa, Naiem T.
    Wathieu, Henri
    Ojo, Abiola
    Byers, Stephen W.
    Dakshanamurthy, Sivanesan
    CURRENT DRUG METABOLISM, 2017, 18 (06) : 556 - 565
  • [2] Strategies for lead optimization: Discovery of new drug candidates.
    Abou-Gharbia, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U36 - U36
  • [3] Imaging in drug discovery, preclinical, and early clinical development
    Wong, Dean F.
    JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (06) : 26N - 28N
  • [4] Early preclinical evaluation of dihydropyrimidin(thi)ones as potential anticonvulsant drug candidates
    Matias, Mariana
    Campos, Goncalo
    Silvestre, Samuel
    Falcao, Amilcar
    Alves, Gilberto
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 102 : 264 - 274
  • [5] STRATEGIES FOR IMPROVING DRUG DEVELOPMENT IN THE EARLY PHASE
    GRIGOLEIT, HG
    PHARMAZEUTISCHE INDUSTRIE, 1984, 46 (05): : 521 - 525
  • [6] Complementary strategies to be used in conjunction with animal models for multiple sclerosis drug discovery: adapting preclinical validation of drug candidates to the need of remyelinating strategies
    Charmarke-Askar, Imane
    Spenle, Caroline
    Bagnard, Dominique
    EXPERT OPINION ON DRUG DISCOVERY, 2024, 19 (09) : 1115 - 1124
  • [7] Strategies of multi-objective optimization in drug discovery and development
    Nicolotti, Orazio
    Giangreco, Ilenia
    Introcaso, Antonellina
    Leonetti, Francesco
    Stefanachi, Angela
    Carotti, Angelo
    EXPERT OPINION ON DRUG DISCOVERY, 2011, 6 (09) : 871 - 884
  • [8] Strategies for early safety assessment of potential drug candidates at Bristol-Myers Squibb: Preclinical evaluation of hepatobiliary toxicity
    Gill, Michael
    Sivaraman, Lakshmi
    Murphy, Brian
    Cheng, Peter
    Chadwick, Kristina
    Graziano, Michael
    Lehman-McKeeman, Lois
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [9] Peptide Optimization at the Drug Discovery-Development Interface: Tailoring of Physicochemical Properties Toward Specific Formulation Requirements
    Evers, Andreas
    Pfeiffer-Marek, Stefania
    Bossart, Martin
    Heubel, Christoph
    Stock, Ursula
    Tiwari, Garima
    Gebauer, Birgit
    Elshorst, Bettina
    Pfenninger, Anja
    Lukasczyk, Ulrike
    Hessler, Gerhard
    Kamm, Walter
    Wagner, Michael
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 108 (04) : 1404 - 1414
  • [10] Strategies for early safety assessment of potential drug candidates at Amgen and lessons learned
    Fielden, Mark
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
12345